Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8201
Reference
MSAN(2024)40
Name
Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and disopyramide (Rythmodan®) 100mg capsules
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Disopyramide (Rythmodan Retard®) 250mg modified-release tablets are out of stock until mid-July 2024.
Disopyramide (Rythmodan®) 100mg capsules will be out of stock from mid-July 2024 until mid-January 2025.
From mid-July, disopyramide (Rythmodan Retard®) 250mg modified-release tablets can support a partial increase in demand.
Alternative treatments to disopyramide remain available.
Unlicensed imports of disopyramide 100mg capsules and disopyramide 250mg MR tablets have been sourced, lead times vary.
Unlicensed specials of disopyramide 25mg/5ml & 50mg/5ml oral suspension are available, lead times vary.
Contact Name
Contact Email
Contact Address
Created
2024-06-28 16:00:00
Click to go back to homepage